Back to AMLX
MARSHALL WACE, LLP AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
11
Latest value
$875K
Q1 2025
Peak value
$42.7M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $33.4M |
| Q2 2023 | $42.7M |
| Q3 2023 | $17.4M |
| Q3 2023 | $4.5M |
| Q4 2023 | $12.3M |
| Q4 2023 | $2.2M |
| Q3 2024 | $266K |
| Q3 2024 | $654K |
| Q4 2024 | $75K |
| Q4 2024 | $623K |
| Q1 2025 | $875K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q1 2025 | $875K | 247.3K | — | — |
| Q4 2024 | $623K | 164.9K | — | — |
| Q4 2024 | $75K | 19.7K | — | — |
| Q3 2024 | $654K | 202.0K | — | — |
| Q3 2024 | $266K | 82.0K | — | — |
| Q4 2023 | $2.2M | 148.3K | — | — |
| Q4 2023 | $12.3M | 836.8K | — | — |
| Q3 2023 | $4.5M | 244.8K | — | — |
| Q3 2023 | $17.4M | 952.9K | — | — |
| Q2 2023 | $42.7M | 1.98M | — | — |
| Q1 2023 | $33.4M | 1.14M | — | — |